Shopping Cart
- Remove All
- Your shopping cart is currently empty
Labradimil is a bradykinin B2 receptor agonist. Labradimil increases the permeability of human brain microvascular endothelial cell monolayers. Labradimil enhances delivery of hydrophilic chemotherapeutics and increases survival in rats with metastatic tumors in the brain. Labradimil increases carboplatin levels in brain tumors after pretreatment with dexamethasone.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
25 mg | $1,520 | Backorder | |
50 mg | $1,980 | Backorder | |
100 mg | $2,500 | Backorder |
Description | Labradimil is a bradykinin B2 receptor agonist. Labradimil increases the permeability of human brain microvascular endothelial cell monolayers. Labradimil enhances delivery of hydrophilic chemotherapeutics and increases survival in rats with metastatic tu |
Alias | RMP-7, Receptor-mediated permeabiliser-7, DRG-0182, DRG0182, DRG 0182, ALK-01-040 |
Molecular Weight | 1098.29 |
Formula | C49H75N15O12S |
Cas No. | 159768-75-9 |
Relative Density. | 1.53 |
Storage | keep away from moisture | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.